WIPO publishes three IndulgeRx patent applications for IRX FOODSCORE

IndulgeRx Brands says the World Intellectual Property Organization has published all three of its PCT patent applications for the AI-powered IRX FOODSCORE platform after each earned an all-A international search report. The company says the result strengthens its intellectual property position as it prepares for seed, Series A and partnership talks.

Why it matters: - IndulgeRx says the WIPO publications give the company public, government-verified patent momentum around IRX FOODSCORE®, its AI-powered nutrition scoring platform. - The company says the result strengthens the intellectual property moat behind its planned consumer, licensing, retail, payer, provider, pharmacist, sports performance, research and government use cases. - IndulgeRx says the milestone supports upcoming seed round and Series A discussions, plus strategic partnership talks.

What happened: - WIPO published all three of IndulgeRx Brands Inc.'s Patent Cooperation Treaty applications on July 23, 2026. - Each application earned an International Search Report with only “A” references, and no “X” or “Y” citations. - The three published applications cover IRX FOODSCORE® as a system, as software and as a business method. - The published application numbers are WO2026156106 A1 for IRX FS SOFTWARE, WO2026156110 A1 for IRX FS METHOD and WO2026156104 A1 for IRX FS SYSTEM.

The details: - IndulgeRx says the International Searching Authority for the applications found every claim novel, inventive and industrially applicable. - The company says the written opinions covered claims 1–15 in each filing. - Patent counsel said the examiner could not find any single reference or combination that defeats the claims. - The company says the public record includes a locked priority date of January 16, 2025. - Patent counsel said one filing required a minor procedural claim-grouping clarification that did not affect the “A” grades or novelty findings. - IndulgeRx says the platform analyzes a person's health history, age, gender, medications and goals against ingredients, additives, preservatives and preparation methods. - The system produces two outputs: a Relevant Nutrition Score and a Relevant Risk Score. - IndulgeRx says the product turns “is this good for me?” into one IRX FOODSCORE® answer. - The company provided more information at the company’s website, the IRX FOODSCORE page and Fight Back Foods.

Between the lines: - The patent outcome does not equal commercial success, but it can help reduce perceived risk for investors, acquirers and partners evaluating the company’s technology. - IndulgeRx is positioning the search report as independent validation that its claims are distinct from prior art in health AI and nutrition tech. - The company is also using the result as proof that a small, self-funded team can clear the same patent process faced by larger technology companies.

What's next: - IndulgeRx is signaling that the publication may feed into fundraising, licensing and partnership conversations. - The company is likely to keep building around the IRX FOODSCORE® IP portfolio as the published applications move through the next patent stages. - The public WIPO record now gives outside parties a fixed reference point for the three filings and their priority date.